Banque Cantonale Vaudoise Invests $2.56 Million in Mettler-Toledo International, Inc. (NYSE:MTD)

Key Points

• Banque Cantonale Vaudoise has invested approximately $2.56 million in Mettler-Toledo International by acquiring 2,169 shares during the first quarter.
• Mettler-Toledo reported an earnings per share (EPS) of $8.19, exceeding analyst expectations of $7.90, although revenue decreased by 4.6% compared to the previous year.
• Institutional investors hold 95.07% of Mettler-Toledo's stock, reflecting strong interest from numerous hedge funds and investment firms in recent quarters.

Banque Cantonale Vaudoise bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,169 shares of the medical instruments supplier's stock, valued at approximately $2,561,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Mettler-Toledo International during the 4th quarter valued at approximately $44,000. Golden State Wealth Management LLC raised its position in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 35 shares during the period. Menard Financial Group LLC purchased a new stake in shares of Mettler-Toledo International during the 4th quarter valued at approximately $67,000. Blue Trust Inc. raised its position in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after purchasing an additional 52 shares during the period. Finally, Farther Finance Advisors LLC raised its position in Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after purchasing an additional 25 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Performance

NYSE MTD traded down $34.91 during trading hours on Friday, hitting $1,198.77. The company had a trading volume of 339,593 shares, compared to its average volume of 176,982. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01. The company has a market cap of $24.91 billion, a PE ratio of 29.89, a price-to-earnings-growth ratio of 3.89 and a beta of 1.37. The business has a 50 day moving average of $1,191.95 and a 200-day moving average of $1,194.36.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the firm posted $9.65 earnings per share. Mettler-Toledo International's revenue for the quarter was up 3.9% on a year-over-year basis. Sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director owned 120 shares in the company, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.94% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

MTD has been the topic of a number of research analyst reports. Evercore ISI boosted their target price on Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the company an "outperform" rating in a research report on Tuesday, July 8th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their target price for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research note on Monday, April 7th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,139.00 to $1,210.00 and gave the stock a "neutral" rating in a research note on Monday. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and a consensus target price of $1,298.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.